Alberta Health and Wellness made changes to their Pandemic (H1N1) 2009 Influenza Clinical Decision-Making Tool recently. The revised copy is now posted on the ACP website.
Significant change: Under Laboratory Testing.
Laboratory testing for pH1N1 will be limited to hospitalized patients with severe illness, the Tarrant Flu Watch program, and MOH-investigated outbreaks.
Minor change: Under Treatment with Tamiflu.
Reporting information for serious adverse events related to antivirals added.
Minor changes: Under Management of Mild Illness.
- Update to self isolation period for those who work/interact with populations at high risk for influenza-related complications, i.e., self-isolation for 7 days after illness onset or until symptoms resolve and they are feeling well enough to fully participate in normal day-to-day activities, whichever is longer.
- Update to bullet three. Changed 1-2 meters to 2 meters for the distance to maintain between individuals in the household.
Originally published in the November 17, 2009, issue of The Link